CompaniesSSS International Clinical Research

SSS International Clinical Research

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (24)
View all

Total Trials

24

As Lead Sponsor

7

As Collaborator

17

Total Enrollment

1,276

By Phase

PHASE1: 3PHASE2/PHASE3: 1NA: 6PHASE4: 5PHASE3: 1

By Status

COMPLETED: 16TERMINATED: 4RECRUITING: 2ACTIVE_NOT_RECRUITING: 1WITHDRAWN: 1
Clinical Trials Pipeline24 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
2027
2028
2029
2030
2031
Today
NCT00598754
NCT00598767
NCT00415181
NCT01169233
NCT00968344
NCT06782971
Hover over trial bars to see details

Recent Trials

NCT06782971Lead Sponsor
Evaluation of Combined Sensitising and Hypomethylating Therapy Outcomes in AML PDX
N/ARecruiting
25 participants
Started: Jun 6, 2025 · Completed: Mar 31, 2030
NCT05636514Lead Sponsor
Combined Evaluation of Epigenetic and Sensitising Therapy in AML and MDS
PHASE1Recruiting
12 participants
Started: Dec 14, 2022 · Completed: Dec 5, 2025
NCT04337450Collaborator
DTG/3TC Fixed Dose Formulations for the Maintenance of Virological Suppression in Children With HIV Infection Aged 2 to <15 Years Old
PHASE2/PHASE3Active, not recruiting
386 participants
Started: Apr 22, 2022 · Completed: Sep 30, 2025
NCT03097523Collaborator
Mitigating Cephalad Fluid Shifts: A NSBRI Study
NACompleted
3 participants
Started: Jan 1, 2017 · Completed: May 31, 2017
NCT02755493Collaborator
Quantifying and Developing Countermeasures for the Effect of Fatigue-Related Stressors on Automation Use and Trust During Robotic Supervisory Control
NACompleted
22 participants
Started: Apr 30, 2016 · Completed: May 31, 2018
View all 24 trials →
Related Companies
Optimapharma Group
acquired